NO173556C - Monoklonalt antistoff som gjenkjenner alpha-2-3-bindinger, og hybridomcellelinje som produserer antistoffet - Google Patents
Monoklonalt antistoff som gjenkjenner alpha-2-3-bindinger, og hybridomcellelinje som produserer antistoffetInfo
- Publication number
- NO173556C NO173556C NO885113A NO885113A NO173556C NO 173556 C NO173556 C NO 173556C NO 885113 A NO885113 A NO 885113A NO 885113 A NO885113 A NO 885113A NO 173556 C NO173556 C NO 173556C
- Authority
- NO
- Norway
- Prior art keywords
- monoclonal antibody
- binding
- alpha
- cell line
- antibody
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57469—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving tumor associated glycolinkage, i.e. TAG
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/806—Drug, bio-affecting and body treating compositions involving IgM
- Y10S424/807—Monoclonal
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
- Y10S530/864—Monoclonal
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Oncology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62290310A JP2754206B2 (ja) | 1987-11-17 | 1987-11-17 | α2→3結合を認識するモノクローナル抗体 |
Publications (4)
Publication Number | Publication Date |
---|---|
NO885113D0 NO885113D0 (no) | 1988-11-16 |
NO885113L NO885113L (no) | 1989-05-18 |
NO173556B NO173556B (no) | 1993-09-20 |
NO173556C true NO173556C (no) | 1993-12-29 |
Family
ID=17754449
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO885113A NO173556C (no) | 1987-11-17 | 1988-11-16 | Monoklonalt antistoff som gjenkjenner alpha-2-3-bindinger, og hybridomcellelinje som produserer antistoffet |
Country Status (14)
Country | Link |
---|---|
US (1) | US5141864A (fi) |
EP (1) | EP0316882B1 (fi) |
JP (1) | JP2754206B2 (fi) |
KR (1) | KR960014441B1 (fi) |
CN (1) | CN1042734A (fi) |
AT (1) | ATE108482T1 (fi) |
AU (1) | AU624583B2 (fi) |
CA (1) | CA1337800C (fi) |
DE (1) | DE3850634T2 (fi) |
FI (1) | FI95043C (fi) |
HU (1) | HU204573B (fi) |
IL (1) | IL88400A (fi) |
NO (1) | NO173556C (fi) |
NZ (1) | NZ226974A (fi) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4107154A1 (de) * | 1990-10-11 | 1992-04-16 | Boehringer Mannheim Gmbh | Monoklonale antikoerper gegen melanom |
DE4208795A1 (de) * | 1992-03-19 | 1993-09-23 | Behringwerke Ag | Monoklonaler anti-gangliosid-antikoerper, seine herstellung und verwendung als tumortherapeutikum |
CN1057128C (zh) * | 1993-09-22 | 2000-10-04 | 南通医学院 | 感觉神经抗体及其制备方法 |
US5674681A (en) * | 1994-12-06 | 1997-10-07 | Rothenberg; Barry E. | Methods to identify hemochromatosis |
CU23007A1 (es) * | 2001-04-06 | 2004-12-17 | Ct De Inmunologia Molecular Ct De Inmunologia Mole | Combinaciones inmunoterapéuticas para el tratamiencombinaciones inmunoterapéuticas para el tratamiento de tumores que sobre-expresan gangliósidos to de tumores que sobre-expresan gangliósidos |
KR20060002879A (ko) * | 2003-03-28 | 2006-01-09 | 자이단호진 토야마켄 신세키 산교기코 | 1개의 항원 특이적 b림프구를 이용한 항원 특이적 항체를생산하는 하이브리도마의 제조방법 및 단일 클론 항체의제조방법 |
FI20070199A0 (fi) * | 2007-03-08 | 2007-03-08 | Glykos Finland Oy | Uusia happamia N-glykaanirakenteita |
EP2606897A1 (en) * | 2011-12-22 | 2013-06-26 | Laboratorios Del. Dr. Esteve, S.A. | Methods and compositions for the treatment of diseases caused by enveloped viruses |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4507391A (en) * | 1982-04-02 | 1985-03-26 | Sloan-Kettering Institute For Cancer Research | Method for detecting the presence of GD3 ganglioside |
-
1987
- 1987-11-17 JP JP62290310A patent/JP2754206B2/ja not_active Expired - Lifetime
-
1988
- 1988-11-11 KR KR1019880014846A patent/KR960014441B1/ko not_active IP Right Cessation
- 1988-11-14 US US07/270,205 patent/US5141864A/en not_active Expired - Fee Related
- 1988-11-15 EP EP88119045A patent/EP0316882B1/en not_active Expired - Lifetime
- 1988-11-15 DE DE3850634T patent/DE3850634T2/de not_active Expired - Fee Related
- 1988-11-15 FI FI885279A patent/FI95043C/fi not_active IP Right Cessation
- 1988-11-15 NZ NZ226974A patent/NZ226974A/en unknown
- 1988-11-15 AT AT88119045T patent/ATE108482T1/de not_active IP Right Cessation
- 1988-11-16 CA CA000583272A patent/CA1337800C/en not_active Expired - Fee Related
- 1988-11-16 CN CN88107887A patent/CN1042734A/zh active Pending
- 1988-11-16 HU HU885935A patent/HU204573B/hu not_active IP Right Cessation
- 1988-11-16 NO NO885113A patent/NO173556C/no unknown
- 1988-11-17 IL IL88400A patent/IL88400A/xx not_active IP Right Cessation
- 1988-11-17 AU AU25186/88A patent/AU624583B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
DE3850634T2 (de) | 1994-10-27 |
FI95043C (fi) | 1995-12-11 |
JPH01132374A (ja) | 1989-05-24 |
KR890008320A (ko) | 1989-07-10 |
EP0316882B1 (en) | 1994-07-13 |
NO885113L (no) | 1989-05-18 |
HUT48679A (en) | 1989-06-28 |
NZ226974A (en) | 1990-03-27 |
FI885279A0 (fi) | 1988-11-15 |
FI885279A (fi) | 1989-05-18 |
IL88400A (en) | 1993-06-10 |
AU2518688A (en) | 1989-05-25 |
DE3850634D1 (de) | 1994-08-18 |
KR960014441B1 (ko) | 1996-10-15 |
HU204573B (en) | 1992-01-28 |
CN1042734A (zh) | 1990-06-06 |
NO885113D0 (no) | 1988-11-16 |
CA1337800C (en) | 1995-12-26 |
ATE108482T1 (de) | 1994-07-15 |
NO173556B (no) | 1993-09-20 |
FI95043B (fi) | 1995-08-31 |
EP0316882A3 (en) | 1990-03-14 |
AU624583B2 (en) | 1992-06-18 |
IL88400A0 (en) | 1989-06-30 |
US5141864A (en) | 1992-08-25 |
EP0316882A2 (en) | 1989-05-24 |
JP2754206B2 (ja) | 1998-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT86792A (pt) | Monoclonal antibodies against melanoma-associated antigens hybrid cell lines producing these antibodies and use therefor | |
DK609985A (da) | Adhesin-antigener, antistoffer mod disse og dna-fragmenter, som indkoder antigenerne | |
FR14C0070I1 (fr) | Procede de la production des anticorps humanises | |
IL61876A0 (en) | Monoclonal antibody to a human t cell antigen,its production and compositions containing it | |
SE8300290D0 (sv) | Process for the production of human mono-clonal antibodies | |
YU45068B (en) | Process for obtaining a monoclonal antibody which is fixing a complement | |
NO173556C (no) | Monoklonalt antistoff som gjenkjenner alpha-2-3-bindinger, og hybridomcellelinje som produserer antistoffet | |
DK392387D0 (da) | Monoklonalt antistrof til diagnostisk anvendelse og fremgangsmaade til fremstilling af et saadan antistof | |
SE8103198L (sv) | Forfarande for framstellning av antikroppar | |
EP0251195A3 (en) | Method and reagent for the determination of alpha-amylase | |
DK440988A (da) | Monoklonalt antistof, som er specifikt over for neutrophilocyter | |
DK227184D0 (da) | Agarfibre indeholdende deri immobiliserede enzymholdige mikroorganismeceller og fremgangsmaade til fremstilling deraf | |
FI873233A (fi) | Modifierade virala glykoproteiner. | |
NO174632C (no) | Monoklonale antistoffer som er i stand til å gjenkjenne gangliosider GQ1B og GT1A og en hyberidom som produserer disse antistoffene |